A remarkable case showcases a woman who was treated with CAR-T-cell therapy for nerve-cell cancer at the age of 4, remaining cancer-free for 19 years, the longest known remission from this treatment. Despite CAR-T-cell therapies being effective in blood cancers, success in solid tumors remains a challenge. Additionally, two intriguing research studies are discussed: one involving the scent analysis of Egyptian mummies to explore preservation methods, and the other investigating how a protein variant, NOVA1, could influence language development in humans by comparing changes in mice vocalizations.
A woman who underwent CAR-T-cell therapy for nerve cancer at age 4 has been cancer-free for 19 years, marking the longest remission recorded.
Researchers are exploring the smell of Egyptian mummies by analyzing air samples from sarcophagi, hoping to recreate scents for museum exhibitions.
A unique protein variant, NOVA1, might have influenced spoken language evolution, as mice genetically altered to express the human version exhibited more complex vocalizations.
Success with CAR-T-cell therapy in blood cancers highlights challenges in treating solid tumors, emphasizing the importance of the long-term success story seen in this case.
Collection
[
|
...
]